This article outlines the key changes associated with Active Ingredient Prescribing, the reasons for its introduction and the practicalities in relation to its application in the primary care setting.

Written by Dr Charlotte Middleton BMBS, DipCH, FRACGP, CHIA (Health Informatics)

Dr Charlotte Middleton is Chief Medical Officer for MedicalDirector and a practising GP with 23 years clinical experience. Dr Middleton specialises in integrative medicine and has a keen interest in the role of technology in healthcare. As MedicalDirector’s CMO, Dr Middleton provides clinical oversight of all their products, including their cloud-based practice management software, Helix.